IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Novocure Limited. & Advises Investors with Losses to ...
December 22 2016 - 4:57AM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces that it is investigating Novocure Limited. (“Novocure” or
the “Company”) (Nasdaq: NVCR) concerning possible violations of
federal securities laws.
If you purchased or otherwise acquired Novocure shares and would
like more information regarding the investigation, we encourage you
to contact Michael Goldberg or Brian Schall, of Goldberg Law PC,
1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
Novocure creates and markets treatment for solid tumor cancers
therapy called the tumor treating fields (“TTFields”). Novocure
advertises its proprietary therapy, TTFields delivery system,
through the Optune name as a monotherapy treatment for adult
patients with glioblastoma brain cancer.
Novocure revealed that its new Optune prescriptions dropped to
657 in the second quarter from 755 in the first. Asaf Danziger,
Chief Executive Officer of Novocure, stated, “[w]hile barriers to
full adoption remain, I am optimistic we will overcome the
challenges inherent in bringing a completely new therapy into
widespread clinical use.”
When this information was disclosed to the public, Novocure’s
stock fell over 29%, causing investors serious harm.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at
info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161222005221/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Apr 2023 to Apr 2024